Risk of lymphoma increases with hepatitis C virus infectionMay 09, 2007People infected with the hepatitis C virus (HCV) are at an increased risk of developing certain lymphomas (cancers of the lymphatic system), according to a study published in the May 8, 2007, issue of the Journal of the American Medical Association. Researchers from the National Cancer Institute (NCI), part of the National Institutes of Health, and Baylor College of Medicine, found that HCV infection increased the risk of developing non-Hodgkin's lymphoma by 20 percent to 30 percent. The risk of developing Waldenström's macroglobulinemia (a rare type of non-Hodgkin's lymphoma) went up by 300 percent and the risk for cryoglobulinemia, a condition marked by abnormal levels of certain antibodies in the blood, was also elevated for those with HCV infections. The researchers looked at patient records collected from Veterans Affairs (VA) hospitals across the United States between 1996 and 2004. Researchers selected more than 700,000 records; 146,394 represented patients who were diagnosed with the hepatitis C virus, while 572,293 represented patients who were not. Based on that review, researchers determined, first, that the patients infected with HCV had a higher risk of developing lymphoma and, second, that HCV infection preceded development of the lymphoma. The risk of lymphomas in HCV-infected patients was charted across more than five years of follow-up. "This is one of the largest studies ever conducted to look at the relationship between hepatitis C virus infection and cancers of the lymphatic system," said NCI Director John E. Niederhuber, M.D. "Since so much is still unknown about the causes of lymphoma, establishing which factors contribute to the disease is the first step in finding ways to reduce its incidence and lessen mortality."
HCV causes hepatitis, which is an inflammation of the liver. The HCV virus is carried through the blood and is passed from person to person through the exchange of bodily fluids -- via shared needles, open wounds, and sexual contact, among other means. HCV is also known to cause cirrhosis and liver cancer. "Although the risk of developing lymphomas is small, our research suggests that screening of HCV-infected individuals could identify conditions which may lead to cancer. It might then be possible to prevent progression to lymphoma," said investigator Eric A. Engels, M.D., from the Viral Epidemiology Branch of NCI's Division of Cancer Epidemiology and Genetics. "More research is needed to further clarify the relationship between HCV infection and lymphoma." In the United States, there are more than 4.1 million people living with hepatitis C virus infection -- about 1.6 percent of the population. In 2007, it is estimated that 71,380 Americans will be diagnosed with some type of lymphoma, which will take 19,730 lives. The researchers note that this study was limited to military veterans who used the VA system, so the results may not be applicable to the overall U.S. population. The study population was mostly men (97 percent), the majority of patients were white, and the average age was 52 years. Patients in the HCV-infected group were more likely to have served during the Vietnam era (1964-1975) than were uninfected patients in the comparison group. Previous studies found that the prevalence of HCV infection is much higher among U.S. veterans who use the VA medical system (5 percent) than in the general population, where only 1.6 percent carry the virus. Several factors have likely contributed to this higher prevalence, including demographics, socioeconomic status, and particularly a history of injection drug use or blood transfusions received before 1990, when screening for hepatitis C virus was started. NIH/National Cancer Institute Science News and Science Current Events Tag Cloud This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size. Flavanols Cancer Cell Space Exploration Quasar Adult Stem Cells Memories Ferroelectric Ibuprofen Bird Flu Mussels Oxygen Anxiety Algae Oral Contraceptive Cyclones Emissions Osteoarthritis Seizures Galaxy Clusters Fragile X Syndrome Contraception Bullying Carbon Dioxide Fingerprint San Andreas Fault
See More: Science News Tags | |||||||||||||||||||||
|
Related Hepatitis Current Events and Hepatitis News Articles Young offenders' health critical to rehabilitation The physical and mental health needs of juvenile offenders should be treated as a priority if offenders held in detention have any real hope of rehabilitation, according to new research from the University of Adelaide, Australia. Transplant drug stimulates immune memory Rapamycin, a drug given to transplant recipients to suppress their immune systems, has a paradoxical effect on cells responsible for immune memory, scientists at the Emory Vaccine Center have discovered. Good news for some hard-to-treat hepatitis C patients In a multi-center trial led by a Saint Louis University researcher, investigators found that a new combination therapy of daily consensus interferon and ribavirin helps some hepatitis C patients who have not responded to previous treatment. FibroTest attributes to generate decision trees in hepatitis C In recent years the use of non-invasive biomarkers to assess liver fibrosis has become widely accepted. DKK-3 and WIF-1: Proteins related to liver cancer development? Liver cancer is one of the most fatal human malignancies and the third most frequent cause of tumor-related death, about half a million people globally each year. Low-fat diet helps genetically predisposed animals avoid liver cancer In a study comparing two strains of mice, one susceptible to developing cancer and the other not, researchers found that a high-fat diet predisposed the cancer-susceptible strain to liver cancer, and that by switching to a low-fat diet early in the experiment, the same high-risk mice avoided the malignancy. Subclinical markers predict relapse in juvenile idiopathic arthritis post methotrexate withdrawal Elevated levels of the inflammatory biomarkers Myeloid Related Protein (MRP) 8/14 predict an increased risk of relapse following withdrawal of methotrexate (MTX) therapy in children with juvenile idiopathic arthritis (JIA) who have achieved inactive disease status. NEJM Study Points to New Era in Hepatitis C Treatment For patients with the most common form of hepatitis C, the addition of a hepatitis C-specific protease inhibitor called telaprevir to the current standard therapy can significantly improve the chances of being cured, and it does it in half the time of standard therapy alone. MicroRNAs grease the cell's circadian clockwork Most of our cells possess an internal clock, a group of genes displaying a cyclic expression pattern that reaches a peak once a day. Liver disease 'shrunk' by blood-pressure drug A blood-pressure medicine has been shown to reverse the effects of early-stage liver failure in some patients. More Hepatitis Current Events and Hepatitis News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||